How to Integrate Novel Treatment Classes for R/R Myeloma Into Clinical Practice: Information on Selinexor, Venetoclax, and Melphalan Flufenamide
In this podcast episode, Tiffany Richards, PhD, ANP-BC, AOCNP, discusses the key data and nursing considerations for integrating novel classes of agents into the treatment plan for R/R MM, with a focus on combinations with selinexor, venetoclax and melphalan flufenamide.